409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics
409 Development ofex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics